<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p16" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_16{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_16{left:817px;bottom:1132px;}
#t3_16{left:162px;bottom:1085px;letter-spacing:0.11px;word-spacing:2.86px;}
#t4_16{left:162px;bottom:1067px;letter-spacing:0.11px;word-spacing:0.04px;}
#t5_16{left:162px;bottom:1050px;letter-spacing:0.1px;word-spacing:-0.5px;}
#t6_16{left:162px;bottom:1032px;letter-spacing:0.1px;word-spacing:0.01px;}
#t7_16{left:162px;bottom:1015px;letter-spacing:0.14px;}
#t8_16{left:289px;bottom:1015px;letter-spacing:0.11px;word-spacing:0.21px;}
#t9_16{left:162px;bottom:997px;letter-spacing:0.11px;word-spacing:0.03px;}
#ta_16{left:141px;bottom:940px;letter-spacing:0.15px;}
#tb_16{left:162px;bottom:919px;letter-spacing:0.14px;}
#tc_16{left:162px;bottom:884px;letter-spacing:0.12px;word-spacing:0.03px;}
#td_16{left:279px;bottom:884px;letter-spacing:0.13px;word-spacing:0.03px;}
#te_16{left:162px;bottom:867px;letter-spacing:0.12px;word-spacing:0.87px;}
#tf_16{left:162px;bottom:850px;letter-spacing:0.11px;word-spacing:0.95px;}
#tg_16{left:162px;bottom:832px;letter-spacing:0.11px;word-spacing:0.03px;}
#th_16{left:162px;bottom:797px;letter-spacing:0.14px;}
#ti_16{left:251px;bottom:797px;letter-spacing:0.11px;word-spacing:-0.63px;}
#tj_16{left:162px;bottom:779px;letter-spacing:0.11px;word-spacing:0.6px;}
#tk_16{left:162px;bottom:762px;letter-spacing:0.11px;word-spacing:2.91px;}
#tl_16{left:162px;bottom:744px;letter-spacing:0.1px;word-spacing:0.02px;}
#tm_16{left:162px;bottom:726px;letter-spacing:0.13px;word-spacing:3.29px;}
#tn_16{left:319px;bottom:726px;letter-spacing:0.12px;word-spacing:3.28px;}
#to_16{left:162px;bottom:709px;letter-spacing:0.11px;word-spacing:1.51px;}
#tp_16{left:162px;bottom:691px;letter-spacing:0.12px;word-spacing:3.58px;}
#tq_16{left:162px;bottom:674px;letter-spacing:0.11px;word-spacing:0.02px;}
#tr_16{left:162px;bottom:656px;letter-spacing:0.12px;}
#ts_16{left:220px;bottom:656px;letter-spacing:0.11px;word-spacing:0.7px;}
#tt_16{left:162px;bottom:639px;letter-spacing:0.1px;word-spacing:-0.6px;}
#tu_16{left:162px;bottom:621px;letter-spacing:0.1px;word-spacing:-0.57px;}
#tv_16{left:162px;bottom:604px;letter-spacing:0.11px;word-spacing:1.9px;}
#tw_16{left:162px;bottom:586px;letter-spacing:0.11px;word-spacing:0.02px;}
#tx_16{left:162px;bottom:568px;letter-spacing:0.13px;word-spacing:3.68px;}
#ty_16{left:346px;bottom:568px;letter-spacing:0.12px;word-spacing:3.68px;}
#tz_16{left:162px;bottom:551px;letter-spacing:0.12px;word-spacing:5.03px;}
#t10_16{left:162px;bottom:533px;letter-spacing:0.12px;word-spacing:6.11px;}
#t11_16{left:162px;bottom:516px;letter-spacing:0.11px;word-spacing:0.03px;}
#t12_16{left:162px;bottom:498px;letter-spacing:0.14px;}
#t13_16{left:298px;bottom:498px;letter-spacing:0.11px;word-spacing:0.27px;}
#t14_16{left:162px;bottom:480px;letter-spacing:0.12px;word-spacing:0.04px;}
#t15_16{left:162px;bottom:411px;letter-spacing:0.52px;word-spacing:-0.53px;}
#t16_16{left:162px;bottom:377px;letter-spacing:0.52px;word-spacing:-0.53px;}
#t17_16{left:141px;bottom:322px;letter-spacing:0.14px;}
#t18_16{left:201px;bottom:322px;letter-spacing:0.15px;}
#t19_16{left:290px;bottom:322px;letter-spacing:0.14px;}
#t1a_16{left:162px;bottom:300px;letter-spacing:0.13px;}
#t1b_16{left:162px;bottom:266px;letter-spacing:0.13px;word-spacing:0.03px;}
#t1c_16{left:162px;bottom:248px;letter-spacing:0.13px;word-spacing:6.3px;}
#t1d_16{left:162px;bottom:231px;letter-spacing:0.11px;word-spacing:0.03px;}
#t1e_16{left:162px;bottom:195px;letter-spacing:0.11px;word-spacing:2.69px;}
#t1f_16{left:162px;bottom:178px;letter-spacing:0.11px;word-spacing:1.07px;}
#t1g_16{left:162px;bottom:160px;letter-spacing:0.11px;word-spacing:-0.37px;}
#t1h_16{left:162px;bottom:143px;letter-spacing:0.1px;word-spacing:0.68px;}
#t1i_16{left:162px;bottom:125px;letter-spacing:0.11px;word-spacing:0.99px;}
#t1j_16{left:162px;bottom:108px;letter-spacing:0.13px;word-spacing:6.88px;}
#t1k_16{left:162px;bottom:90px;letter-spacing:0.1px;}
#t1l_16{left:204px;bottom:90px;letter-spacing:0.13px;word-spacing:1.29px;}
#t1m_16{left:366px;bottom:90px;letter-spacing:0.11px;word-spacing:1.29px;}

.s0_16{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_16{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_16{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s3_16{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s4_16{font-size:27px;font-family:Calibri-Light_8c;color:#000;-webkit-text-stroke:0.7px #000;text-stroke:0.7px #000;}
.s5_16{font-size:18px;font-family:TimesNewRomanPS-BoldItalicMT_8s;color:#000;}
.s6_16{font-size:15px;font-family:TimesNewRomanPS-ItalicMT_8n;color:#000;}
.t.v0_16{transform:scaleX(1.02);}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts16" type="text/css" >

@font-face {
	font-family: Calibri-Light_8c;
	src: url("fonts/Calibri-Light_8c.woff") format("woff");
}

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldItalicMT_8s;
	src: url("fonts/TimesNewRomanPS-BoldItalicMT_8s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-ItalicMT_8n;
	src: url("fonts/TimesNewRomanPS-ItalicMT_8n.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg16Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg16" style="-webkit-user-select: none;"><object width="935" height="1210" data="16/16.svg" type="image/svg+xml" id="pdf16" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_16" class="t s0_16">Brain: Chemistry to Cognition </span><span id="t2_16" class="t s1_16">8 </span>
<span id="t3_16" class="t s0_16">patients. Our findings contribute to a better understanding of the role of the gut microbiome/intestinal </span>
<span id="t4_16" class="t s0_16">permeability in SCZ pathophysiology and to identify high risk individuals using gut microbiome signatures. </span>
<span id="t5_16" class="t s0_16">Further research in this area has potential for the development of novel neuropyschobiotic-based therapeutics </span>
<span id="t6_16" class="t s0_16">to treat neuropsychiatric diseases. </span>
<span id="t7_16" class="t s2_16">Acknowledgements</span><span id="t8_16" class="t s0_16">: This work is supported by research grants from NIMHANS and DHR, Govt. of India. </span>
<span id="t9_16" class="t s0_16">JN was supported by fellowship from ICMR. </span>
<span id="ta_16" class="t s3_16">S1.5. Self-propagating neurotoxicity of APP-C31 drives key pathogenic pathways </span>
<span id="tb_16" class="t s3_16">implicated in Alzheimer’s disease </span>
<span id="tc_16" class="t s0_16">Pawan Kumar and </span><span id="td_16" class="t s2_16">Gavin S. Dawe </span>
<span id="te_16" class="t s0_16">Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine; Department of </span>
<span id="tf_16" class="t s0_16">Pharmacology, Yong Loo Lin School of Medicine; and Neurobiology Programme, Life Sciences Institute, </span>
<span id="tg_16" class="t s0_16">National University of Singapore, Singapore </span>
<span id="th_16" class="t s2_16">Background: </span><span id="ti_16" class="t s0_16">The amyloid-β precursor protein (APP) undergoes caspase cleavage, resulting in the formation </span>
<span id="tj_16" class="t s0_16">of the cytotoxic APP-C31 fragment. APP-C31 potentially plays a crucial role in Alzheimer's Disease (AD) </span>
<span id="tk_16" class="t s0_16">progression. However, our understanding of this neurotoxin is still limited, particularly concerning the </span>
<span id="tl_16" class="t s0_16">mechanisms that trigger its generation and continued production. </span>
<span id="tm_16" class="t s2_16">Materials and methods</span><span id="tn_16" class="t s0_16">: We investigated caspase cleavage of APP in post-mortem brain and dermal </span>
<span id="to_16" class="t s0_16">fibroblasts from AD patients. We studied effects of APP-C31 on phosphorylation of APP and activity of </span>
<span id="tp_16" class="t s0_16">caspase 3 in SH-SY5Y neuronal cells, and explored interferon-γ mediated neurotoxic effects in BV2 </span>
<span id="tq_16" class="t s0_16">microglial and SH-SY5Y cell cultures. </span>
<span id="tr_16" class="t s2_16">Results: </span><span id="ts_16" class="t s0_16">We found an association of caspase-cleaved APP with AD in human subjects. In cellular models, </span>
<span id="tt_16" class="t s0_16">we identified that APP-C31 could enhance its own neurotoxicity by increasing the availability of a competent </span>
<span id="tu_16" class="t s0_16">substrate, the phosphorylated form of APP, and the activity of the catalytic enzyme, caspase 3. We also found </span>
<span id="tv_16" class="t s0_16">potential neuron-glia interactions whereby APP-C31 can raise interferon-γ levels and stimulate the Stat1 </span>
<span id="tw_16" class="t s0_16">inflammatory pathway in microglia, which in turn compromises neuronal health. </span>
<span id="tx_16" class="t s2_16">Discussion and conclusions</span><span id="ty_16" class="t s0_16">: Our findings indicate that APP-C31 may sustain its own neurotoxicity, </span>
<span id="tz_16" class="t s0_16">potentially contributing cumulatively to the progression of underlying pathology in AD. Therefore, </span>
<span id="t10_16" class="t s0_16">developing therapeutic strategies to target the APP-C31 neurotoxin could potentially mitigate the </span>
<span id="t11_16" class="t s0_16">pathophysiology associated with AD. </span>
<span id="t12_16" class="t s2_16">Acknowledgements: </span><span id="t13_16" class="t s0_16">This research was supported by the Ministry of Education, Singapore, under its MOE </span>
<span id="t14_16" class="t s0_16">AcRF Tier 3 Award MOE2017-T3-1-002. </span>
<span id="t15_16" class="t v0_16 s4_16">Symposium-2: Deciphering neural functions in health and </span>
<span id="t16_16" class="t v0_16 s4_16">diseases: emerging fronts </span>
<span id="t17_16" class="t s3_16">S2.1. A </span><span id="t18_16" class="t s5_16">Drosophila </span><span id="t19_16" class="t s3_16">genetic model to study the molecular and physiological pathways of </span>
<span id="t1a_16" class="t s3_16">epileptic disorder </span>
<span id="t1b_16" class="t s2_16">Shamprasad Varija Raghu </span>
<span id="t1c_16" class="t s0_16">Division of Neuroscience, Yenepoya Research Centre (YRC), Yenepoya (Deemed to University), </span>
<span id="t1d_16" class="t s0_16">Deralakatte, Mangalore, Karnataka 575018 </span>
<span id="t1e_16" class="t s0_16">Epilepsy is a chronic neurological disorder that affects more than 70 million people worldwide with a </span>
<span id="t1f_16" class="t s0_16">considerable social and economic burden. Relapses and unprovoked spontaneous seizures characterize the </span>
<span id="t1g_16" class="t s0_16">disorder. The most common antiepileptic treatments are pharmaceutical. However, in most epilepsy patients, </span>
<span id="t1h_16" class="t s0_16">drug therapy cannot control seizures. Despite different alternative treatments such as dietary control, nerve </span>
<span id="t1i_16" class="t s0_16">stimulation, and surgery, some patients still do not improve. Therefore, there is an urgent need to develop </span>
<span id="t1j_16" class="t s0_16">more effective protocols for the diagnosis and treatment of epilepsy. The genetically amenable </span>
<span id="t1k_16" class="t s0_16">model </span><span id="t1l_16" class="t s6_16">Drosophila melanogaster </span><span id="t1m_16" class="t s0_16">offers several genetic tools to mimic different human neuronal disorders, </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
